Table 2. Baseline characteristics of the study population.
| Characteristics | All | PC (n=3) | ICC (n=5) |
|---|---|---|---|
| Age, mean ± SD (year) | 69.4±6.9 | 68.7±7.6 | 69.8 ±7.3 |
| Sex, male/female | 2/6 | 0/3 | 2/3 |
| Comorbidity, present | 8 | 3 (100%) | 5 (100%) |
| ECOG performance status | |||
| 0 | 3 (100%) | 4 (80%) | |
| 1 | 0 (0%) | 1 (20%) | |
| Mean tumor size, mean ± SD (cm) | 7.7±3.6 | 8.1±6.5 | 7.5±1.1 |
| Tumor distribution, n | |||
| Unilobar | 2 | 2 | |
| Bilobar | 1 | 3 | |
| Tumor burden, <50% of total liver | 0 (0%) | 0 (0%) | |
| Number of tumors, n | |||
| Solitary | 1 | 0 | 1 |
| Multifocal | 7 | 3 | 4 |
| LSF (%), mean ± SD | 9.1±4.5 | 11.1±6.8 | 7.9±2.7 |
| PVT | 1 | 1 | 0 |
| PHT | 1 | 1 | 0 |
| Ascites | 1 | 1 | 0 |
| Invading vessels | 1 | 1 | 0 |
| Extra-hepatic metastasis | 6/2 | 3/0 | 3/2 |
| CA19.9 (U/mL) | |||
| Baseline (mean ± SD) | 2,649.7±7,245.8 | 6,981.0±11,778 | 51.0±45.2 |
| Follow up (mean ± SD) | 3,182.2±8,815.3 | 8,443.3±14,339.3 | 25.6±47.6 |
Values are expressed as n (%) or mean ± standard deviation. PC, pancreatic adenocarcinoma; ICC, intrahepatic cholangiocarcinoma; SD, standard deviation; ECOG, Eastern Cooperative Oncology Group; LSF, lung shunting fraction; PVT, portal venous thrombosis; PHT, portal hypertension.